Kyung Nam Pharm Co.,Ltd.

₩1,516As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:053950Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (21.80%)
Div yield —
ROE (3.29%)
Pharmaceutical Preparations
Beta (5Y) 0.21
PE TTM —
TSR TTM (61.62%)
Mkt cap ₩29.74B
ROIC (0.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,535
1.27%
(92.34%)
Hold 8|3|8|10|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
33.34
34.01
36.64
35.66
1.88%
3.58%
6.93%
2.56%
Revenue₩B
1.478
1.479
1.527
1.598
14.21%
12.93%
10.37%
9.32%
Peers (US$21.93M)
Cap (US$)
PE
22.37M
20.31x
Capital
TTM
5Y
10Y
Leveragex
1.086
0.334
0.298
EBIT/Intx
0.469
3.449
3.528
Own earn%
137.14
108.73
81.04
Sh yield%
23.34
28.02
31.57
Owners
Insiders/Inst%
4.34
49.57
Short interest%
2.47
SBC / revenue%
0.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
5–8
$1 testx
0.0
Incr. ROIC%
0